Tag: claudication
Stenting of the SFA for intermittent claudication yields quality-of-life benefits out...
In a recent study of patients with intermittent claudication (IC) caused by isolated superficial femoral artery (SFA) lesions, researchers found that primary stenting conferred...
Study demonstrates feasibility, effectiveness of at-home exercise therapy plus cognitive behaviour...
A mobile phone-administered, home-based exercise therapy programme for patients with intermittent claudication (IC) incorporating cognitive behaviour therapy (CBT) was found to be feasible, with...
CX 2022 highlights new data in the vascular world
Anticipation is building for the Charing Cross International Symposium 2022 (26–28 April, London, UK, in person and virtual), which this year will address some...
VOYAGER PAD subanalysis highlights risks for claudicants undergoing revascularisation
Principal investigator of the VOYAGER PAD trial, Marc Bonaca (University of Colorado Anschutz Medical Campus, Aurora, USA) speaks to Vascular News about the latest data...
Favourable cost-effectiveness results for endovascular SFA treatment in claudicants
From a cost-effectiveness standpoint, primary stenting of the superficial femoral artery (SFA) for the treatment of intermittent claudication can, in many countries, be used...
Use of wearable activity monitors could benefit intermittent claudication patients, study...
There is some evidence to indicate that the inclusion of wearable activity monitors in home-based exercise therapy improves walking ability and quality of life...
Use of wearable activity monitors could benefit intermittent claudication patients, study...
There is some evidence to indicate that the inclusion of wearable activity monitors in home-based exercise therapy improves walking ability and quality of life...
Outpatient hospitalisation for endovascular repair of claudication not cost-effective in France,...
According to the AMBUVASC randomised controlled trial (RCT), outpatient hospitalisation is not cost-effective compared with inpatient hospitalisation for endovascular repair of patients with claudication...
RCT finds community-based cardiac rehabilitation benefits intermittent claudication patients
A recent randomised controlled trial (RCT)—the CIPIC Rehab study—found that three-months’ community-based cardiac rehabilitation improves walking distance in patients with intermittent claudication. It was...
VEITH 2019: Tackling dehydration has a “tremendous impact” when treating claudication...
Enrico Ascher (New York, USA) interviews Juan Parodi (Buenos Aires, Argentina) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA), about his research on claudication therapy.
Parodi explains...
Benefit and risk: Meta-analysis draws a heterogeneous picture of drug-coated balloon...
Scientists of Jena University Hospital, Germany, conducted a meta-analysis sought to evaluate benefit and risk of paclitaxel-coated balloon angioplasty compared to plain old balloon...
Wearables could transform monitoring and outcome assessment for vascular interventions
Health technology solutions—such as mobile apps and wearables—can play a huge role in activity tracking and assessing the outcomes of peripheral vascular interventions, says...
An intermittent claudication meta-analysis: Findings point to sustained improvements after home...
Temple University’s systematic review and meta-analysis on eight independent intermittent claudication studies using pneumatic compression pumps has shown significant improvements in walking distances even...
Smartphone over treadmill: Mapping claudication with Google Maps
The use of GPS mapping tools has become a cornerstone of modern life. A study published by the Journal of Vascular Surgery has demonstrated...
Cardiovascular Systems releases 30-day results from LIBERTY 360° study
Cardiovascular Systems has released procedural and 30-day results from its LIBERTY 360° study in a late-breaking presentation at the 2016 Amputation Prevention Symposium (AMP;...
